Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,101,922
+$863,843 QoQ
Shares Held
252,939
+116.6% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Sep 30, 2024CallValue
$862,050
CallShares
35,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ARVN ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ARVN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,101,922 | 252,939 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,238,079 | 116,800 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,830,103 | 154,309 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,167,494 | 254,401 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,126,489 | 424,795 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,348,046 | 619,380 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,468,232 | 128,755 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,937,024 | 444,053 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $862,050 | 35,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $3,790,020 | 142,375 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,377,179 | 154,486 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,381,279 | 155,036 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,130,721 | 108,489 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,744,791 | 110,588 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,493,358 | 91,265 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,932,786 | 85,729 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,557,825 | 169,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,399,250 | 175,796 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,960,015 | 177,712 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,805,295 | 228,942 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $16,049,752 | 195,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,733,570 | 126,410 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $5,388,140 | 81,515 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,046,590 | 71,195 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $11,633,755 | 492,747 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,345,944 | 338,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,314,502 | 255,943 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||